Literature DB >> 15178910

Exercise-induced purpura.

Albert-Adrien Ramelet1.   

Abstract

Exercise-induced purpura (EIP) occurs on the lower legs after unusual or major muscular activity, as in marathon runners or as after long walks, especially in the mountains in hot weather. In leisure walkers, patients are otherwise healthy females. There is no relation with chronic venous disorder. Erythematous, urticarial or purpuric plaques arise on the lower leg, usually sparing the skin compressed by socks. Symptoms include itch, pain and a burning sensation. Histopathology demonstrates leukocytoclastic vasculitis. The lesions fade after some days, with frequent relapses at further muscular exercises and may be prevented in some cases by compression, intake of venoactive drugs and local application of steroids. EIP is not uncommon, even if very few descriptions have yet been published. It appears to be consecutive to venous stasis induced by an acute failure of the muscle pump of the calf and thermoregulation decompensation, after a prolonged and unusual exercise, such as running or walking in hot weather. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15178910     DOI: 10.1159/000077837

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

Review 1.  Skin conditions in figure skaters, ice-hockey players and speed skaters: part II - cold-induced, infectious and inflammatory dermatoses.

Authors:  Brook E Tlougan; Anthony J Mancini; Jenny A Mandell; David E Cohen; Miguel R Sanchez
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

Review 2.  Pigmented Purpuric Dermatoses: A Complete Narrative Review.

Authors:  Cristina B Spigariolo; Serena Giacalone; Gianluca Nazzaro
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

3.  Henoch-Schönlein purpura with joint involvement: Analysis of 71 cases.

Authors:  Xuehong Wang; Yongmei Zhu; Laiqiang Gao; Shuyue Wei; Youyou Zhen; Qiang Ma
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-31       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.